SureTrader Nadex Advertisement
Home > Boards > US OTC > Cannabis >

OWC Pharmaceutical Research Corp. (OWCP)

Add OWCP Price Alert      Hide Sticky   Hide Intro
Moderator: Renee, waterchaser, Eagle1, zioni007, Homebrew, dbuss90
Search This Board: 
Last Post: 2/26/2017 1:52:55 PM - Followers: 783 - Board type: Free - Posts Today: 274


OWC Pharmaceutical Research Corp.












Recent Filings
View All Filings on EDGAR Online


*Cannabis Research for Treatments* 

In Israel:
Ziv Turner, Chief Executive Officer - One World Cannabis Ltd.
Email: [email protected]
Tel: +972-(0)3-7582659

In the United States:
Jeffrey Friedland
Email: [email protected]
Tel: +1-646-450-8909
Ticker [OTC : OWCP]  


OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for Multiple Myeloma, Psoriasis, Fibromyalgia, PTSD, Migraines, and unique delivery systems. 

***MUST SEE OWCP Videos & Social Media UPDATED***

OWCP Board of Advisors - Jeffrey Friedland on One World Cannabis

OWCP - Executive Management
Dr. Yehuda Baruch, Dir. of Research & Regulatory Affairs and Dr. Alan Shackelford

OWC Pharma - CEO Ziv Turner

Report on Israel Cannabis Industry

Jeffrey Friedland - Cannabis Expert - OWCP Board
Author of .. “MARIJUANA: The World's Most Misunderstood Plant -
Medical Marijuana Conference

Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today and others

OWCP News 

OWCP - Completion of Medical Cannabis Sublingual Tablet 

OWCP - Psoriasis Crème News 

OWCP Announce Financing and Joint Venture with European Distributor 

OWCP Announce Partnership with Medmar for USA Distribution 

OWCP Research
All Company News Releases, Financial Info and SEC Filings 


Teva Pharmaceuticals [NYSE:TEVA]  interested in OWCP Patents 

Dr. Ben-Zion Weiner of TEVA was among the original investors in OWCP, and is advising the Company. 
Dr. Ben-Zion Weiner was Head of Global Research and Development at Teva Pharmaceutical Industries Ltd. for over three decades, including as Chief R&D Officer and as a member of the Teva Executive Committee.  

USA Cannabis Expert Jeffrey Friedland on Medical Cannabis / Israel and OWCP 

OWCP Videos 

Industry Articles 

Israeli Pharmacies to Start Selling Medical Cannabis 

Israel - Making the Desert Bloom with Cannabis 

Canadian Pharmacies to Start Selling Medical Cannabis 

Marijuana Set To Become Billion Dollar Industry in Canada 

German Pharmacies To Start Selling Medical Cannabis 

South Africa Just Approved Medical Cannabis 

Australia Cannabis to be Legalized 

NY Times - Marijuana Company Prepares to Cross State Lines 

USA States with Legal Cannabis 

OWCP Pharma Board of Advisors - Jeffrey Friedland Blog 

Follow OWCP on Social Media 



OWCP Web Site

Follow on Investors Hub [iHub
] – Investors Forum 

Jan 17, 2017 Letter  to OWCP  Shareholders
OWCP's Action Items for 2017:
During the second quarter of 2017 OWCP intends to initiate its U.S marketing program for its Psoriasis Topical Cream. At the same time, we intend to begin investigating the applicability of topical cream for other skin conditions and disorders.

OWCP intends to proceed with the advancement of our cannabis-based treatment for multiple myeloma, with the objective of proceeding with additional studies.
OWCP intends to evaluate the launch of one or more studies to determine the applicability of cannabinoid-based pharmaceuticals for other medical conditions and disorders, such as fibromyalgia and migraines.

Why am I so confident in OWCP?  Here are 16 reasons from 2016!

  1. #16.Though it didn’t take place in 2016, it’s still huge. TEVA, a 115 year old pharmaceutical company with over $20B in revenue, made an offer to purchase OWCP’s patents!  This leads me to believe there will be future offers as OWCP continues to
    advance their research and get closer to shipping products worldwide!

OWCP: Market Potential of Upcoming Products

So, as I’ve pointed out – a handful of Cannabis/Marijuana companies with billions of Outstanding Shares, generating little or no revenue, posting annual losses, and who are still being financed with (Toxic) Convertible Notes achieving a Market Value of $115M all the way to $424M (for a company with $2.1M revenue, but still with billions of shares)… Why on God’s green Earth would OWCP not climb to dollars per share? (Note: $2/share is a $280M Market Value)

OWCP: Annual Letter to Shareholders

Jeffrey Friedland:

I’ve pointed out in our Year End Recap that Jeffrey Friedland is a huge asset. Quite frankly, I’m a fan of Mr. Friedland. He’s all over the Medical Marijuana industry events.

Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, VersloZinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, and Forbe

OWCP: Recent TEVA Pharma Buyouts

Here’s how I came up with my $500M valuation (which, is quite possibly very conservative):

  1. OWCP has NO TOXIC Debt
    That was announced in an 8-K back in October. (This isn’t some OTC Pink Sheet operation.)  They have real investors.  That same October 8-K talks about a $300,000 non-interest bearing loan.  They have royalty-based distribution deals with MedMar and Michepro, because the distributor obviously has confidence too.

I would recommend to my friends, do some DD and look up what OWCP may be working on with their Patent for Nasal Spray

Cannabis Nasal Spray can stop seizures in their tracks,
these sprays can also be used for Parkinson Disease
and pain from Cancers
epileptic seizure
Also Cannabis Nasal Sprays can help with Brain Cancer
(for people who have trouble swallowing these sprays really help)

Cannabis nasal spray stop grand mal seizure in children




Jeffrey Friedland to Give the Keynote Address at The Wall St. Conference on March 1st

In attendance at The Wall St. Conference, founded by Jason S. Lyons, will be senior and elite Wall Street professionals, including industry leaders from the hedge fund, investment banking, and equity worlds, in addition to sophisticated investors.

March 1, OWCP  spent $100,000.00 for a Diamond Sponsor Spot. Previously OWCP had a $50,000.00 Platinum Sponsor Spot !!!!!

$100,000.00 Diamond Sponsor

  • Name recognition on the entire event
    Recognition as main event sponsor on all marketing material
    Key booth slot
    Premium speaking slot
    Listing in the Professionals Guide Book

A $50,000.00 Increase  !!!


PETACH TIKVA, Israel, January 27, 2017 /PRNewswire/ --

OWC Pharmaceutical Research Corp. (OWCP), ("OWC" or the "Company"), an Israeli-based developer of cannabinoid-based therapies targeting a variety of medical conditions and disorders, today announced that
Ms. Miri Sani has accepted nomination to the Company's Advisory Board.


OWCP: The Blessing of Some Investors “Not Getting It”

If you’re able to buy under $1.50/share — I really think that’s a “blessing” because I really, really think it’s obvious the shares will be worth $4.00 – $5.00 by end of Quarter 2.  After all, the Sublingual Tablet could very well have some updates/progress and expected launch dates announced sometime in Quarter 2 as well.

OWCP positions itself to sell in Germany, the world's 3rd largest medical market. Miri Sani, Vice Chairwoman (Israel)
"Israel is one of the most innovative countries in the world with regard to life sciences. Main areas are medical devices, biotechnology and health-related software. Some Israeli firms are world-leaders (TEVA, Given Imaging) in specific sub-segments of the life-science industry. However, most life-science-based companies are SMEs. These SMEs have difficulties in getting access to markets. The Israeli domestic market is small. The market entry into the US is expensive and risky due to high regulatory standards. Israeli firms tend to underestimate growth opportunities in continental Europe. Even though Germany has the third largest market for medical devices in the world, this market is often not high on the priority list of Israeli SMEs. The main hurdles are a general lack of information about Germany as a business location for life science firms and the difficulties in understanding the specifics of the German health care system. There is a variety of European, Federal, State and local incentive and support programs available for R&D in Germany for foreign and domestic firms alike, but the evaluation of these programs is time-consuming and can be discouraging for Israeli SMEs."


OWC Is On Fire With Over A 1200% Gain In 4 Months.

Its targeted market areas are Israel, the European Union, South America, Canada and the U.S. Its a big market for a good product. As an example, Statista forecasts that the cannabinoid-based pharmaceuticals market in the U.S will be $2 billion in 2020 and increase to $50 billion by 2029. There is no telling how large the worldwide market will become.

$OWCP: "Ready for its multi-Dollar Run?"

Finally, OWCP put out an official PR about presenting at Lyons Capital’s “Wall Street Conference” (where OWCP is listed as a ‘Diamond’ sponsor, by the way) on March 1st in Boca Raton, FL. OWCP Advisory Board member, Jeffrey Friedland, is giving a 30 minute presentation. A brief description of this conference: “The WALL ST. Conference is the premiere conference in the venture capital arena and Small Cap marketplace. The most senior and elite Wall Street professionals attend this conference. Industry leaders from the hedge fund, investment banking, and private equity worlds, as well as sophisticated investors, all attend the WALL ST. Conference every year to discuss significant trends in the industry.

Video, Donald Trump Wants To Legalize Marijuana

President-elect Trump has made it clear that he supports medical marijuana.

6 Reasons Why Marijuana Wins No Matter Who Becomes Attorney General - See more at:

Feb 16, 2017 Video, Cannabis Caucus Federal and State level

  OWCP included in NEW, "First Ever" Cannabis ETF!

The ETF Filing

READ, FEB 16, 2017 OWCP being ADDED TO Cannabis ETF What it Means.
"This is surprisingly great news and all out of the blue!"

**UPDATED** OWCP Corp Presentation  PDF

Feb 21, 2017 OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Could Be The Next GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)

At minute 4;30 you will hear the efficacy study to be completed March 20, 2017 for the  Psoriasis Cream ! Market readiness 2nd Quarter 2017  

."Shareholders Meeting in Reno November 2017"
Staying at Circus Circus, Exact Dates and times TBA.
If you're interested in attending please send an email to Pussim
at [email protected]
Please include your ihub handle and your real name along with contact information.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
OWCP News: Current Report Filing (8-k) 02/24/2017 04:03:55 PM
OWCP News: Current Report Filing (8-k) 02/07/2017 06:06:08 AM
OWCP News: Current Report Filing (8-k) 02/02/2017 09:15:23 AM
OWCP News: Current Report Filing (8-k) 01/26/2017 05:15:05 PM
OWCP News: Cannabis Industry Sees Cautionary Optimism amid Trump Administration Uncertainty 01/25/2017 08:30:00 AM
#58666  Sticky Note TAX TALK: Please find a tax specific forum Homebrew 02/26/17 09:47:24 AM
#57819  Sticky Note Doc you realize what we Own !!! Cherry 02/24/17 06:54:01 PM
#56726  Sticky Note Moderator Note: Three new board Mods have been Renee 02/23/17 08:56:51 PM
#58833   I see. They will split the PROFITS 75% pichon1 02/26/17 01:52:55 PM
#58832   Rowdy, seeing as you bought in October probably matzaball 02/26/17 01:51:48 PM
#58831   Well I'm not selling any of my shares. Cherry 02/26/17 01:50:09 PM
#58829   Hold on tight! I know I will be! RowdyHoward 02/26/17 01:47:58 PM
#58828   Well, if G*PH gets it's way only FDA Triple9 02/26/17 01:47:17 PM
#58827   Thanks for the info!! RowdyHoward 02/26/17 01:47:14 PM
#58826   Thanks!! RowdyHoward 02/26/17 01:46:29 PM
#58825   See what I mean? Even more better. zombywolf 02/26/17 01:45:10 PM
#58824   If no-one is willing to sell at low jm101dm 02/26/17 01:41:56 PM
#58823   The terms of the two contacts they signed Triple9 02/26/17 01:41:24 PM
#58822   Nice post. Member mark for you! Triple9 02/26/17 01:39:48 PM
#58820   This is a fantastic point. CBD oil is Santes8 02/26/17 01:38:52 PM
#58819   Don´t get caught in a time-trap ..... planetaryfuture 02/26/17 01:38:02 PM
#58818   Let it go. Don't let stuff like Triple9 02/26/17 01:29:55 PM
#58817   People have to want to buy for it Dumotier21 02/26/17 01:28:11 PM
#58816   I don't like to be stressed about my Triple9 02/26/17 01:26:47 PM
#58815   Additionally, don't people have to sell for the RowdyHoward 02/26/17 01:24:28 PM
#58814   So you're saying hold for a couple yrs? RowdyHoward 02/26/17 01:23:39 PM
#58813   Accept it isn't just CBD. That would be Dumotier21 02/26/17 01:23:05 PM
#58812   Right, I guess I don't have a strategy RowdyHoward 02/26/17 01:20:57 PM
#58811   OWC is not a manufacturer. zombywolf 02/26/17 01:20:16 PM
#58810   That sounds reasonable enough. Goldman Sachs has assigned an Camelot 02/26/17 01:19:47 PM
#58809   OWCP Looking Like A Trustworthy Winner ...... planetaryfuture 02/26/17 01:19:18 PM
#58808   I think it will hit 5 easy, I FlyingPig10 02/26/17 01:15:55 PM
#58807   Use net EPS and increase your P/E to 100 zombywolf 02/26/17 01:14:15 PM
#58806   Pharma Industry Profit Margins pichon1 02/26/17 01:12:32 PM
#58805   If they continue to make progress on their matzaball 02/26/17 01:12:05 PM
#58803   Two months to one year short term should Mistafixit 02/26/17 01:10:22 PM
#58802   I can't speak for others, but i got Dumotier21 02/26/17 01:10:00 PM
#58801   Here's what OTC markets have DigitalTradz 02/26/17 01:07:56 PM
#58800   Charted a TRIPLE BOTTOM @ ~$1.50. I must Nikodemos 02/26/17 01:06:58 PM
#58799   We do 128 percent last Tuesday on zero Camelot 02/26/17 01:06:12 PM
#58798   I calculated a conservative revenue figure of zombywolf 02/26/17 01:06:07 PM
#58797   Now wait a minute, LOL!!!! Arent you guys pichon1 02/26/17 01:02:38 PM
#58796   Psoriasis alone is huge, also treatment of other Mistafixit 02/26/17 12:57:17 PM
#58795   If TEVA can stump up $40bn for another Shazbat 02/26/17 12:54:59 PM
#58794   I agree with that. I'm a business owner RowdyHoward 02/26/17 12:54:09 PM
#58793   Last float report I see is zombywolf 02/26/17 12:53:56 PM
#58792   Good luck to you Israel is where madtrader2132 02/26/17 12:53:31 PM
#58791   This has turned my whim penny trading account 1-800-stfu 02/26/17 12:53:06 PM
#58790   I have, however, it has the same chart chrispy1 02/26/17 12:51:44 PM
#58789   I ended up selling more @.07 then when williamjf77 02/26/17 12:47:34 PM
#58788   No argument from me. I was just trying Dumotier21 02/26/17 12:44:10 PM
#58787   Wow hope you still have over 100k. Glad jk1283 02/26/17 12:43:57 PM
#58786   Read the DD on this page you madtrader2132 02/26/17 12:43:23 PM
#58785   What makes this any different and less of chrispy1 02/26/17 12:42:04 PM
#58784   Remember their cream probably will have the worst madtrader2132 02/26/17 12:40:48 PM
#58783   That will be something special. Meet the man Moonbound 02/26/17 12:40:21 PM
#58782   Sometimes but not always..other than that i a General Grievous 02/26/17 12:39:06 PM
#58781   Why is that an issue? Psoriasis is a Dumotier21 02/26/17 12:38:39 PM